Platelet functional and transcriptional changes induced by intralipid infusion

Summary

Multiple studies have shown the effects of long-term exposure to high-fat or western diets on the vascular system. There is limited knowledge on the acute effects of high circulating fat levels, specifically on platelets, which have a role in many processes, including thrombosis and inflammation. This study investigated the effects of acute, high-fat exposure on platelet function and transcript profile. Twenty healthy participants were given an intravenous infusion of 20% Intralipid emulsion and heparin over 6 hours. Blood samples were taken prior to and the day after infusion to measure platelet function and transcript expression levels. Platelet aggregation was not significantly affected by Intralipid infusion, but, when mitochondria function was inhibited by carbonyl cyanide 3-chlorophenylhydrazone (CCCP) or oligomycin, platelet aggregation was higher in the post-infusion state compared to baseline. Through RNA sequencing, and verified by RT-qPCR, 902 miRNAs and 617 mRNAs were affected by Intralipid infusion. MicroRNAs increased include miR-4259 and miR-346, while miR-517b and miR-517c are both decreased. Pathway analysis identified two clusters significantly enriched, including cell motility. In conclusion, acute exposure to high fat affects mitochondrial-dependent platelet function, as well as the transcript profile.

Keywords

Clinical studies - gene expression - platelet physiology - obesity

^* Co-First Authors.

^† Deceased.

• References

• 1 Mozaffarian D, Benjamin EJ, Go AS. et al. Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 2015; 131: e29-322.
• 2 Bohnert R, Ratsch G. rQuant.web: a tool for RNA-Seq-based transcript quantitation. Nucleic Acids Res 2010; W348-351.
• 3 Katz Y, Wang E, Airoldi E. et al. Large analysis and design of RNA sequencing experiments for identifying isoform regulation. Nature Methods 2010; 07: 1009-1015.
• 4 Nicolae M, Mangul S, Mandoiu I. et al. Estimation of alternative splicing isoform frequencies from RNA-Seq data. Algorithms Bioinf Lect Notes Comp Sci 2010; 202-214.
• 5 Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Meth 2012; 09: 357-359.
• 6 Zheng L, Feng Y, Shi Y. et al. Intralipid decreases apolipoprotein M levels and insulin sensitivity in rats. PLoS One 2014; 09: e105681.
• 7 Stojiljkovic MP, Lopes HF, Zhang D. et al. Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 2002; 20: 1215-1221.
• 8 Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nature Rev Genet 2009; 10: 57-63.
• 9 Gosmanov AR, Smiley DD, Robalino G. et al. Effects of oral and intravenous fat load on blood pressure, endothelial function, sympathetic activity, and oxidative stress in obese healthy subjects. Am J Physiol Endocrinol Metab 2010; 299: E953-958.
• 10 Li B, Dewey C. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics 2011; 12: 323.
• 11 Beaulieu LM, Lin E, Mick E. et al. Interleukin 1 receptor 1 and interleukin 1beta regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans. Arterioscler Thromb Vasc Biol 2014; 34: 552-564.
• 12 Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 2014; 30: 2114-2120.
• 13 Davis MPA, van Dongen S, Abreu-Goodger C. et al. A set of tools for quality control and analysis of high-throughput sequence data. Methods 2013; 63: 41-49.
• 14 Love M, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15: 550.
• 15 Merico D, Isserlin R, Stueker O. et al. Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualisation and Interpretation. PLoS One 2010; 05: e13984.
• 16 Huang D, Sherman B, Tan Q. et al. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyse large gene lists. Genome Biol 2007; 08: 183.
• 17 Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protocols 2008; 04: 44-57.
• 18 Freedman JE, Larson MG, Tanriverdi K. et al. Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study. Circulation 2010; 122: 119-129.
• 19 McManus DD, Beaulieu LM, Mick E. et al. Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk. Arterioscler Thromb Vasc Biol 2013; 33: 2666-2673.
• 20 Aviram M, Deckelbaum RJ. Intralipid infusion into humans reduces in vitro platelet aggregation and alters platelet lipid composition. Metabolism 1989; 38: 343-347.
• 21 Jarnvig IL, Naesh O, Hindberg I. et al. Platelet responses to intravenous infusion of Intralipid in healthy volunteers. Am J Clin Nutr 1990; 52: 628-631.
• 22 Patel S, Puranik R, Nakhla S. et al. Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins. Atherosclerosis 2009; 204: 424-428.
• 23 Herson VC, Block C, Eisenfeld L. et al. Effects of intravenous fat infusion on neonatal neutrophil and platelet function. JPEN J Parenter Enteral Nutr 1989; 13: 620-622.
• 24 Dube JJ, Coen PM, DiStefano G. et al. Effects of acute lipid overload on skeletal muscle insulin resistance, metabolic flexibility, and mitochondrial performance. Am J Physiol Endocrinol Metab 2014; 307: E1117-1124.
• 25 Van Way 3rd CW, Dunn EL, Hamstra RD. The effect of intravenous safflower oil emulsion on the clotting mechanism. Am Surg 1983; 49: 460-464.
• 26 Burnham WR, Heptinstall S, Cockbill SR. et al. Blood platelet behaviour during infusion of an Intralipid-based intravenous feeding mixture. Postgrad Med J 1982; 58: 152-155.
• 27 Kapp JP, Duckert F, Hartmann G. Platelet adhesiveness and serum lipids during and after Intralipid infusions. Nutr Metab 1971; 13: 92-99.
• 28 Wang CH, Wang CC, Huang HC. et al. Mitochondrial dysfunction leads to impairment of insulin sensitivity and adiponectin secretion in adipocytes. FEBS J 2013; 280: 1039-1050.
• 29 Ravi S, Chacko B, Sawada H. et al. Metabolic plasticity in resting and thrombin activated platelets. PLoS One 2015; 10: e0123597.
• 30 Kramer PA, Ravi S, Chacko B. et al. A review of the mitochondrial and glycolytic metabolism in human platelets and leukocytes: implications for their use as bioenergetic biomarkers. Redox Biol 2014; 02: 206-210.
• 31 Freedman JE. Oxidative stress and platelets. Arterioscler Thromb Vasc Biol 2008; 28: s11-16.
• 32 Krotz F, Sohn HJ, Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 2004; 24: 1988-1996.
• 33 Carnevale R, Bartimoccia S, Nocella C. et al. LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis 2014; 237: 108-116.
• 34 Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 1989; 65: 378-387.
• 35 Dasarathy S, Kasumov T, Edmison JM. et al. Glycine and urea kinetics in nonalcoholic steatohepatitis in human: effect of intralipid infusion. Am J Physiol Gastrointest Liver Physiol 2009; 297: G567-575.
• 36 Shigenaga MK, Hagen TM, Ames BN. Oxidative damage and mitochondrial decay in aging. Proc Natl Acad Sci USA 1994; 91: 10771-10778.
• 37 Finocchietto PV, Franco MC, Holod S. et al. Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med 2009; 234: 1020-1028.
• 38 Freedman JE, Loscalzo J, Barnard MR. et al. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997; 100: 350-356.
• 39 Tomasiak M, Stelmach H, Rusak T. et al. Nitric oxide and platelet energy metabolism. Acta Biochim Pol 2004; 51: 789-803.
• 40 Nakata M, Yada T, Soejima N. et al. Leptin promotes aggregation of human platelets via the long form of its receptor. Diabetes 1999; 48: 426-429.
• 41 Juhan-Vague I, Morange PE, Alessi MC. The insulin resistance syndrome: implications for thrombosis and cardiovascular disease. Pathophysiol Haemost Thromb 2002; 32: 269-273.
• 42 Lindemann S, Tolley ND, Dixon DA. et al. Activated platelets mediate inflammatory signalling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154: 485-490.
• 43 Risitano A, Beaulieu LM, Vitseva O. et al. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood 2012; 119: 6288-6295.
• 44 Garding A, Bhattacharya N, Claus R. et al. Epigenetic upregulation of lncRNAs at 13q14.3 in leukemia is linked to the In Cis downregulation of a gene cluster that targets NF-kB. PLoS Genet 2013; 09: e1003373.
• 45 Du M, Auer PL, Jiao S. et al. Whole-exome imputation of sequence variants identified two novel alleles associated with adult body height in African Americans. Hum Mol Genet 2014; 23: 6607-6615.
• 46 Bratkovic T, Rogelj B. The many faces of small nucleolar RNAs. Biochim Biophys Acta 2014; 1839: 438-443.
• 47 Makarova JA, Ivanova SM, Tonevitsky AG. et al. New functions of small nucleolar RNAs. Biochemistry 2013; 78: 638-650.
• 48 Cavaille J, Seitz H, Paulsen M. et al. Identification of tandemly-repeated C/D snoRNA genes at the imprinted human 14q32 domain reminiscent of those at the Prader-Willi/Angelman syndrome region. Hum Mol Genet 2002; 11: 1527-1538.
• 49 Beaulieu LM, Clancy L, Tanriverdi K. et al. Specific Inflammatory Stimuli Lead to Distinct Platelet Responses in Mice and Humans. PLoS One 2015; 10: e0131688.
• 50 Tampakakis E, Tabit CE, Holbrook M. et al. Intravenous Lipid Infusion Induces Endoplasmic Reticulum Stress in Endothelial Cells and Blood Mononuclear Cells of Healthy Adults. J Am Heart Assoc. 2016 Epub ahead of print.
• 51 Rondina MT, Weyrich AS. Regulation of the genetic code in megakaryocytes and platelets. J Thromb Haemost 2015; (13) (Suppl. 01) S26-32.